Cohen Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cohen Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-660	Closed	-$217K	–	153
2024 Q4	$217K	Hold	660	–	–	0.04%	146
2024 Q3	$221K	Buy	+660	New	+$210K	0.04%	145
2024 Q2	–	Sell	-660	Closed	-$228K	–	145
2024 Q1	$228K	Hold	660	–	–	0.04%	132
2023 Q4	$213K	Hold	660	–	–	0.04%	132
2023 Q3	$237K	Hold	660	–	–	0.05%	125
2023 Q2	$250K	Hold	660	–	–	0.05%	126
2023 Q1	$316K	Hold	660	–	–	0.06%	122
2022 Q4	$278K	Sell	660 -75	-10%	-$30.3K	0.06%	127
2022 Q3	$307K	Hold	735	–	–	0.07%	126
2022 Q2	$364K	Hold	735	–	–	0.07%	125
2022 Q1	$414K	Hold	735	–	–	0.07%	125
2021 Q4	$555K	Sell	735 -15	-2%	-$11.2K	0.09%	115
2021 Q3	$559K	Hold	750	–	–	0.1%	115
2021 Q2	$483K	Hold	750	–	–	0.08%	118
2021 Q1	$428K	Hold	750	–	–	0.08%	118
2020 Q4	$437K	Hold	750	–	–	0.09%	118
2020 Q3	$387K	Sell	750 -100	-12%	-$50.6K	0.09%	116
2020 Q2	$384K	Hold	850	–	–	0.09%	112
2020 Q1	$298K	Hold	850	–	–	0.09%	108
2019 Q4	$315K	Sell	850 -50	-6%	-$17.6K	0.07%	120
2019 Q3	$299K	Hold	900	–	–	0.07%	122
2019 Q2	$281K	Hold	900	–	–	0.07%	121
2019 Q1	$275K	Hold	900	–	–	0.07%	118
2018 Q4	$209K	Hold	900	–	–	0.06%	122
2018 Q3	$282K	Hold	900	–	–	0.06%	125
2018 Q2	$260K	Hold	900	–	–	0.06%	129
2018 Q1	$228K	Hold	900	–	–	0.05%	131
2017 Q4	$215K	Buy	+900	New	+$218K	0.05%	128
2017 Q3	–	Sell	-900	Closed	-$204K	–	138
2017 Q2	$204K	Hold	900	–	–	0.05%	128
2017 Q1	$179K	Buy	+900	New	+$173K	0.05%	128

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cohen Capital Management's BIO Position: Q1 2025 in Review

Cohen Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 660 shares — an estimated $217K sold.

Cohen Capital Management first reported a position in BIO in Q1 2017 and held it in 30 quarters. The position peaked at $559K in Q3 2021. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

Cohen Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
Cohen Capital Management sold 660 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $217K.
Cohen Capital Management first reported a position in Bio-Rad Laboratories Class A in Q1 2017 and held it in 30 quarters.
Cohen Capital Management's Bio-Rad Laboratories Class A position peaked at $559K in Q3 2021.
436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Cohen Capital Management's 13F filing for Q1 2025, filed 2 May 2025.